What is STERIS's SG&A?

STERIS (STE) reported SG&A of $351.8M in Q1 2026.

How has STERIS's SG&A changed year-over-year?

STERIS's SG&A increased by 5.4% year-over-year, from $333.9M to $351.8M.

What is the long-term trend for STERIS's SG&A?

Over 4 years (2022 to 2026), STERIS's SG&A has grown at a 1.6% compound annual growth rate (CAGR), from $1.32B to $1.41B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

STERIS STE SG&A

SG&A at other companies

Baxter InternationalBAX

$728M+3.6%

EcolabECL

$1.1B+5.0%

3MMMM

$744M-21.3%

StrykerSYK

$2.28B-0.8%

Boston ScientificBSX

$1.78B+11.5%

IAR

Integra LifeSciencesIART

$178.24M-1.8%

Segments

By segment

See full

Healthcare Segment$170.5M+10.3%

Life Sciences:$15.6M+4.0%

AST$15.1M+26.9%

Other financials

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

See full

Market cap$20.52B-9.4%

Enterprise value$22.17B-8.8%

P/E26.2×-8.8×

P/S3.5×-0.6×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's SG&A?: STERIS (STE) reported SG&A of $351.8M in Q1 2026.
How has STERIS's SG&A changed year-over-year?: STERIS's SG&A increased by 5.4% year-over-year, from $333.9M to $351.8M.
What is the long-term trend for STERIS's SG&A?: Over 4 years (2022 to 2026), STERIS's SG&A has grown at a 1.6% compound annual growth rate (CAGR), from $1.32B to $1.41B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.